Uveal Melanoma — Trials

Uveal Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 29
Ph III recruiting: 6
Growth YoY: —
Industry share: 36%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (34)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02678572	Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma(FOCUS)	completed	Phase 3	102	Delcath Systems Inc.INDUSTRY	9	Sep 10, 2026	clinicaltrials
NCT01989572	Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery	completed	Phase 3	815	National Cancer Institute (NCI)NIH	1	Jun 24, 2026